The primary outcome of the study was completion of colorectal cancer screening at six months.
The selection criterion for including the regions in the study was completion of at least three screening rounds by December 2006.
The minimum compliance requirement to be maintained in the study was completion of 80% of the telephone contact forms and other communications and 85% of the assigned exercise sessions.
The time and staff required were usually underestimated by the investigators, but through resourceful efforts, the studies were completed with a remarkably high completion rate.
They will be followed up for 3 years, and the study is scheduled for completion 3 years after the last enrolment.
Antiretroviral therapy (ART) only became available in the public sector as the study was nearing completion.
A condition of enrollment in the study was the completion of a first-year introductory cell biology course.
Criteria for stopping the study were the completion of data collection, or if any of the treatment groups were found to have a substantial increase in adverse clinical outcome(s) or rate of postoperative complications.
The planned date for the completion of the study is 2005.
The study is proceeding on schedule with anticipated completion by August 2002.
